loading

Milestone Pharmaceuticals Inc Azioni (MIST) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
7.39%
3.94
3.669 4.978 3.94 3.963
Operating Income/Loss
5.60%
-11.83
-12.53 -20.52 -12.35 -9.616
Income/Loss From Continuing Operations Before Tax
8.05%
-11.92
-12.97 -20.76 -12.36 -9.439
Income/Loss From Continuing Operations After Tax
8.05%
-11.92
-12.97 -20.76 -12.36 -9.439
Net Income/Loss
8.05%
-11.92
-12.97 -20.76 -12.36 -9.439
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
40.00%
-0.12
-0.20 -0.31 -0.19 -0.14
Diluted Earnings Per Share
40.00%
-0.12
-0.20 -0.31 -0.19 -0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.76
price down icon 0.11%
$99.42
price up icon 1.41%
$51.57
price down icon 1.29%
$88.25
price down icon 1.94%
$143.57
price up icon 0.64%
biotechnology ONC
$282.55
price up icon 0.04%
Capitalizzazione:     |  Volume (24 ore):